Remgro LimitedJSE: REM

REM: Portfolio now 63% private, with growth led by Mediclinic and CIVH, and focus on performance

· Issued by Remgro Limited

Strategic focus has shifted to performance optimization, disciplined capital allocation, and sustainability, with 63% of the portfolio in private assets and a strong Africa-centric approach. Growth drivers include Mediclinic’s transformation and CIVH’s fibre expansion, while portfolio simplification and improved underperforming assets should enhance returns.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Remgro

All Remgro news releases